Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.
Haralabos P KalofonosEmmanouil V DermitzakisGeorgia XiromerisiouDimitrios RallisPanagiotis SoldatosPantelis LitsardopoulosMichail VikelisPublished in: Journal of clinical medicine (2023)
A precise phenotypic profiling with identification of pain characteristics consistent with peripheral and/or central sensitization might reliably predict the responsiveness to fremanezumab in migraine prophylaxis.